Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
Stock Information for Cardiol Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.